Evidence map›Paper›PMID 24554743›Full record

ArticleJournal of medical microbiology2014

Characterization of enterotoxigenic Escherichia coli strains isolated from Nicaraguan children in hospital, primary care and community settings.

Samuel Vilchez, Sylvia Becker-Dreps, Erick Amaya, Claudia Perez, Margarita Paniagua, Daniel Reyes, Felix Espinoza, Andrej Weintraub

Open access · greenAbstract read
In one paragraph

Article in Journal of medical microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Epidemiology of enterotoxigenicFrontiers in microbiology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Samuel VilchezDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Sylvia Becker-DrepsDepartment of Family Medicine, University of North Carolina at Chapel Hill, 590 Manning Drive, Chapel Hill, NC, USA.
Erick AmayaDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Claudia PerezDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Margarita PaniaguaDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Daniel ReyesDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Felix EspinozaDepartment of Microbiology, Faculty of Medical Sciences, National Autonomous University of Nicaragua (UNAN), León, Nicaragua.
Andrej WeintraubDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, S-141 86, Stockholm, Sweden.
National Autonomous University of Nicaragua · NIKarolinska Institutet · SEUniversidad Nacional Autónoma de Nicaragua-León · NIUniversity of North Carolina at Chapel Hill · US

Funding

Preliminary Effectiveness Analysis of Universal Rotavirus Immunization, NicaraguaK01TW008401 · FIC · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BECKER-DREPS, SYLVIA IRENE · 2009 to 2012
$507k
FIC NIH HHS K01 TW008401FIC NIH HHS K01TW008401-04
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) is one of the most common causes of diarrhoea among young children in developing countries. ETEC vaccines offer promise in reducing the burden of ETEC disease, but the development of these vaccines relies on the characterization of ETEC isolates from a variety of settings. To best reflect the full spectrum of ETEC disease in León, Nicaragua, the aim of this study was to characterize ETEC strains isolated from children with diarrhoea attending different settings (hospital, primary care clinics and in the community) and children from different age groups. We characterized ETEC isolates in terms of their colonization factors (CFs) and enterotoxins, and determined whether these factors varied with setting and age group. Diarrhoeal stool samples were obtained from children under the age of 60 months from: (1) the regional public hospital, (2) four public primary care clinics, and (3) a population-based cohort. In total, 58 ETEC-positive isolates were analysed by multiplex-PCR assays for the identification of CFs (CS1, CS2, CS3, CS4, CS5, CS6, CS7, CS8, CS12, CS13, CS14, CS15, CS17, CS18, CS19, CS20, CS21, CS22 and CFA/I), and enterotoxins [heat-labile toxin (LT) and heat-stable variants STh and STp]. The frequency of CFs and enterotoxins was compared among the three settings and for different age groups, using Fisher's exact test or a χ(2) test. At least one CF was detected among one-half of samples; CS19 was detected among all strains in which a CF was identified, either alone or in combination with another CF. Among all CFs detected, 91.7 % were identified as members of the class 5 fimbrial family. CFs were detected more commonly among samples from infants captured in the health facility setting compared with the community setting. Overall, LT was detected among 67.2 % of samples, STh was detected among 20.7 % and both enterotoxins were detected among 12.1 %. The enterotoxin STh was detected more commonly among cases in the community, whilst a combination of STh and LT was detected more commonly among cases treated in health facilities. Our results suggest that, to protect against diarrhoeal cases associated with this E. coli pathotype in León, Nicaragua, an ETEC vaccine that effectively targets the archeotype CFA/I of the class 5 fimbrial family would be the most effective in this setting.

Indexed as

Bacterial ToxinsChild, PreschoolCommunity-Acquired InfectionsCross InfectionDiarrheaEnterotoxigenic Escherichia coliEnterotoxinsEscherichia coli InfectionsEscherichia coli ProteinsEscherichia coli VaccinesFecesFemaleFimbriae ProteinsGenetic VariationHospitalsHumansBacterial Toxinscolonization factor antigensEnterotoxinsEscherichia coli ProteinsEscherichia coli VaccinesFimbriae Proteinsheat-labile enterotoxin, E coliheat stable toxin (E coli)

Identifiers

PMID24554743
PMCPMC4042496
OpenAlexW2000991220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.